Dermatology - European Medical Journal

Continue

Dermatology

Filter
5 Jun 2024

JAK Inhibitors: A New Frontier in Dermatology

JAK INHIBITORS have changed dermatology, and will continue to change dermatology in ways that no other class of drugs has…
1 Mins
12 Feb 2024

Author Response to: Letter To the Editor Concerning ‘Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm’

The aim of our work was to underline that surgery can be applied as a first-line treatment. This was also the shared starting assumption…
15 Mins
30 Jan 2024

Exploring Advancements and Challenges in Adjuvant Melanoma Treatment

Melanoma of the skin is a common type of cancer that primarily affects younger patients. In Stage III melanoma, which does not involve…
1 Mins
25 Jan 2024

Letter To the Editor Concerning ‘Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm’

We agree that the topic of treatment of penile lichen sclerosus in boys is important, and needs more attention in clinical research and…
7 Mins
23 Nov 2023

Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas

Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…
8 Mins
23 Nov 2023

Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity

Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…
2 Mins
23 Nov 2023

Efficacy and Safety of Upadacitinib in a Phase II Randomised, Double-Blind, Dose-Ranging Study of Adults with Extensive Non-segmental Vitiligo

Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…
10 Mins
23 Nov 2023

A New Landmark for Wellbeing in Psoriasis: The POSITIVE Study

Psoriatic disease is a chronic, inflammatory immune condition affecting more than 40 million individuals worldwide…